Physician

Mark Snowise, MD

According to 2025 Medicare claims, Mark Snowise, MD (NPI: 1629036116) practices family practice in the Pittsfield, MA market, with the plurality of this provider's patient population coming from Berkshire, MA. This provider's primary affiliated billing organization is SUBURBAN INTERNAL MEDICINE, INC. (NPI: 1659381192; TIN: 043532606) and primary practice location at 01238-9316. Snowise is affiliated with the Aledade 205 New England MSSP Enhanced (ACO ID: A5370) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Snowise's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 637 traditional Medicare patients, billed 2,892 HCPCS/CPT codes, and received $153,513 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 4,732 prescription claims across 428 beneficiaries totaling $394,897 in drug costs, led by Eliquis (Apixaban). DME data shows 140 claims. Open Payments data shows 16 records totaling $354. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $119,085 to $153,513. Similarly, Part D prescription costs have moved sharply higher in recent years, from $155,564 to $394,897. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $12,984 and ending at $14,389.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$77K$154K2015 Medicare payment: $119,085 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $106,933 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $91,276 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $122,796 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $108,518 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $92,740 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $128,204 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $123,965 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $150,547 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $153,513 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154172,286$119,085
20164102,303$106,933
20173982,014$91,276
20184942,453$122,796
20193562,155$108,518
20203631,939$92,740
20213782,271$128,204
20223992,390$123,965
20236602,889$150,547
20246372,892$153,513

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$197K$395K2015 Drug cost: $155,564 (USD; Tot_Drug_Cst)2016 Drug cost: $176,455 (USD; Tot_Drug_Cst)2017 Drug cost: $177,802 (USD; Tot_Drug_Cst)2018 Drug cost: $216,961 (USD; Tot_Drug_Cst)2019 Drug cost: $251,672 (USD; Tot_Drug_Cst)2020 Drug cost: $209,319 (USD; Tot_Drug_Cst)2021 Drug cost: $288,197 (USD; Tot_Drug_Cst)2022 Drug cost: $311,722 (USD; Tot_Drug_Cst)2023 Drug cost: $372,827 (USD; Tot_Drug_Cst)2024 Drug cost: $394,897 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152873,425$155,564
20163243,761$176,455
20173563,834$177,802
20184424,875$216,961
20193814,840$251,672
20203513,874$209,319
20213724,216$288,197
20223734,202$311,722
20234364,565$372,827
20244284,732$394,897

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.9K$7.9K2015 Medicare payment: $7,893 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,091 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $2,033 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,653 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $3,705 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $4,666 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $2,961 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $2,474 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $856 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $3,980 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201531140$7,893
20161596$3,091
201717100$2,033
201817161$2,653
201912173$3,705
202012169$4,666
202113140$2,961
202211115$2,474
2023N/R72$856
2024N/R140$3,980

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit262262$135
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more157238$89
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more483770$57
G0444Annual depression screening, 5 to 15 minutes261261$20
96160Administration and interpretation of patient-focused health risk assessment166166$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban954,760$90,874
XareltoRivaroxaban462,490$43,315
OzempicSemaglutide391,092$35,288
JardianceEmpagliflozin251,290$25,212
Breo ElliptaFluticasone/Vilanterol451,680$20,645

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0439Stationary liquid oxygen system, rental; includes container, contents, regulator, flowmeter, humidifier, nebulizer, cannula or mask, & tubingYN/R21$1,549
E0434Portable liquid oxygen system, rental; includes portable container, supply reservoir, humidifier, flowmeter, refill adaptor, contents gauge, cannula or mask, and tubingYN/R21$791
E0601Continuous positive airway pressure (cpap) deviceYN/R24$745
A4332Lubricant, individual sterile packet, eachNN/R12$203
A4253Blood glucose test or reagent strips for home blood glucose monitor, per 50 stripsNN/R24$202

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$354Otsuka America Pharmaceutical, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark Snowise, MD?

Tedicare shows public-source Medicare data for Mark Snowise, MD (NPI 1629036116), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Snowise, MD have ACO affiliation data?

Mark Snowise, MD is shown with ACO affiliation data for Aledade 205 New England MSSP Enhanced (MSSP, ACO ID A5370) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mark Snowise, MD?

Mark Snowise, MD is linked to SUBURBAN INTERNAL MEDICINE, INC. (billing NPI 1659381192) in the available physician profile data.

Does Mark Snowise, MD have Open Payments data?

Mark Snowise, MD has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.